Maryna Basalay
Associate Research ScientistCards
About
Research
Publications
2025
SGLT2 Inhibition Induces Cardioprotection by Increasing Parasympathetic Activity.
Basalay MV, Korsak A, He Z, Gourine AV, Davidson SM, Yellon DM. SGLT2 Inhibition Induces Cardioprotection by Increasing Parasympathetic Activity. Circ Res 2025, 136: 229-231. PMID: 39690446, DOI: 10.1161/CIRCRESAHA.124.324708.Peer-Reviewed Original Research
2024
Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomes.
Beikoghli Kalkhoran S, Basalay M, He Z, Golforoush P, Roper T, Caplin B, Salama AD, Davidson SM, Yellon DM. Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomes. Basic Res Cardiol 2024, 119: 937-955. PMID: 39472324, DOI: 10.1007/s00395-024-01086-6.Peer-Reviewed Original Research
2023
The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin.
Basalay MV, Downey JM, Davidson SM, Yellon DM. The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin. Cardiovasc Drugs Ther 2023 PMID: 38117423, DOI: 10.1007/s10557-023-07541-1.Peer-Reviewed Original Research
2022
Opioids in Acute Coronary Syndromes: Friend or Foe?
Basalay MV, Yellon DM, Davidson SM. Opioids in Acute Coronary Syndromes: Friend or Foe? Cardiovasc Drugs Ther 2022, 36: 1001-1003. PMID: 35793001, DOI: 10.1007/s10557-022-07364-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRemote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.
Bell RM, Basalay M, Bøtker HE, Beikoghli Kalkhoran S, Carr RD, Cunningham J, Davidson SM, England TJ, Giesz S, Ghosh AK, Golforoush P, Gourine AV, Hausenloy DJ, Heusch G, Ibanez B, Kleinbongard P, Lecour S, Lukhna K, Ntsekhe M, Ovize M, Salama AD, Vilahur G, Walker JM, Yellon DM. Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop. Basic Res Cardiol 2022, 117: 39. PMID: 35970954, DOI: 10.1007/s00395-022-00947-2.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2021
Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke.
Nizari S, Basalay M, Chapman P, Korte N, Korsak A, Christie IN, Theparambil SM, Davidson SM, Reimann F, Trapp S, Yellon DM, Gourine AV. Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke. Basic Res Cardiol 2021, 116: 32. PMID: 33942194, DOI: 10.1007/s00395-021-00873-9.Peer-Reviewed Original Research
2020
Targeting myocardial ischaemic injury in the absence of reperfusion.
Basalay MV, Yellon DM, Davidson SM. Targeting myocardial ischaemic injury in the absence of reperfusion. Basic Res Cardiol 2020, 115: 63. PMID: 33057804, DOI: 10.1007/s00395-020-00825-9.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNeuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study.
Basalay MV, Wiart M, Chauveau F, Dumot C, Leon C, Amaz C, Bolbos R, Cash D, Kim E, Mechtouff L, Cho TH, Nighoghossian N, Davidson SM, Ovize M, Yellon DM. Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study. Sci Rep 2020, 10: 16874. PMID: 33037284, DOI: 10.1038/s41598-020-74046-4.Peer-Reviewed Original ResearchCan glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
Basalay MV, Davidson SM, Yellon DM. Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality? Neural Regen Res 2020, 15: 1852-1853. PMID: 32246632, DOI: 10.4103/1673-5374.280313.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsIntracellular sodium elevation reprograms cardiac metabolism.
Aksentijević D, Karlstaedt A, Basalay MV, O'Brien BA, Sanchez-Tatay D, Eminaga S, Thakker A, Tennant DA, Fuller W, Eykyn TR, Taegtmeyer H, Shattock MJ. Intracellular sodium elevation reprograms cardiac metabolism. Nat Commun 2020, 11: 4337. PMID: 32859897, DOI: 10.1038/s41467-020-18160-x.Peer-Reviewed Original Research